Status:
COMPLETED
Premenstrual Syndrome (PMS) and Mindfulness Stress Reduction Program (MSRP)
Lead Sponsor:
NURDİLAN SENER
Collaborating Sponsors:
Kırklareli University
Conditions:
Premenstrual Syndrome
Eligibility:
FEMALE
17-30 years
Phase:
NA
Brief Summary
Premenstrual syndrome (PMS) is a disorder characterized by emotional, physical and behavioral symptoms that increase the severity of the menstrual cycle in women of reproductive age during the luteal ...
Detailed Description
Premenstrual syndrome (PMS) is a disorder characterized by emotional, physical and behavioral symptoms that increase the severity of the menstrual cycle in women of reproductive age during the luteal ...
Eligibility Criteria
Inclusion
- be between the ages of 18-30
- Having a score of 45 or more on the PMS scale
- Regular menstruation (between 21-35 days)
- Knowing Turkish (being literate)
- Read and approve the voluntary consent form
Exclusion
- Having any gynecological disease (abnormal uterine bleeding, uterine fibroids, ovarian cysts, hormonal treatment, etc.),
- Having a chronic or physical illness (having serious hearing and vision problems, vestibular disorders that can cause balance loss)
- Having any problem that prevents communication (such as not knowing Turkish, having impairment in hearing, speaking and understanding abilities)
- Receiving a psychiatric treatment (Pharmacotherapy or psychotherapy)
- Do not use pharmacological or non-pharmacological applications to reduce the symptoms of premenstrual symptoms.
Key Trial Info
Start Date :
February 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT05191108
Start Date
February 21 2022
End Date
April 30 2022
Last Update
June 9 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
NURDİLAN
Elâzığ, Eyalet/Yerleşke, Turkey (Türkiye), 23100
2
Kırklareli Üniversitesi
Kırklareli, Turkey (Türkiye), 39100